vs
Assertio Holdings, Inc.（ASRT）与Rhinebeck Bancorp, Inc.（RBKB）财务数据对比。点击上方公司名可切换其他公司
Assertio Holdings, Inc.的季度营收约是Rhinebeck Bancorp, Inc.的1.0倍（$13.5M vs $13.5M），Rhinebeck Bancorp, Inc.同比增速更快（1701.1% vs -57.9%），过去两年Rhinebeck Bancorp, Inc.的营收复合增速更高（14.0% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
Rhinebeck Bancorp, Inc.是总部位于美国纽约的区域性银行控股企业，旗下运营莱茵贝克银行，主要面向纽约哈德逊谷地区的个人消费者与中小企业提供储蓄、贷款、抵押贷款、财富管理等零售及商业金融服务。
ASRT vs RBKB — 直观对比
营收规模更大
ASRT
是对方的1.0倍
$13.5M
营收增速更快
RBKB
高出1759.0%
-57.9%
两年增速更快
RBKB
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $13.5M |
| 净利润 | — | $2.3M |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | 21.7% |
| 净利率 | — | 17.3% |
| 营收同比 | -57.9% | 1701.1% |
| 净利润同比 | — | 188.0% |
| 每股收益（稀释后） | $-4.54 | $0.21 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTRBKB
| Q4 25 | $13.5M | $13.5M | ||
| Q3 25 | $49.5M | $14.0M | ||
| Q2 25 | $29.2M | $13.1M | ||
| Q1 25 | $26.5M | $12.8M | ||
| Q4 24 | $32.2M | $750.0K | ||
| Q3 24 | $29.2M | $773.0K | ||
| Q2 24 | $31.1M | $10.7M | ||
| Q1 24 | $32.4M | $10.4M |
净利润ASRTRBKB
| Q4 25 | — | $2.3M | ||
| Q3 25 | $11.4M | $2.7M | ||
| Q2 25 | $-16.4M | $2.7M | ||
| Q1 25 | $-13.5M | $2.3M | ||
| Q4 24 | — | $-2.7M | ||
| Q3 24 | $-2.9M | $-8.1M | ||
| Q2 24 | $-3.7M | $975.0K | ||
| Q1 24 | $-4.5M | $1.1M |
营业利润率ASRTRBKB
| Q4 25 | -86.7% | 21.7% | ||
| Q3 25 | 23.2% | 23.9% | ||
| Q2 25 | -27.5% | 26.6% | ||
| Q1 25 | -50.0% | 22.9% | ||
| Q4 24 | -41.9% | -444.9% | ||
| Q3 24 | -10.4% | -1332.3% | ||
| Q2 24 | -11.6% | 11.8% | ||
| Q1 24 | -13.4% | 13.9% |
净利率ASRTRBKB
| Q4 25 | — | 17.3% | ||
| Q3 25 | 23.1% | 19.3% | ||
| Q2 25 | -56.0% | 20.8% | ||
| Q1 25 | -51.1% | 17.9% | ||
| Q4 24 | — | -353.9% | ||
| Q3 24 | -10.0% | -1042.9% | ||
| Q2 24 | -11.8% | 9.2% | ||
| Q1 24 | -13.9% | 10.8% |
每股收益（稀释后）ASRTRBKB
| Q4 25 | $-4.54 | $0.21 | ||
| Q3 25 | $0.11 | $0.25 | ||
| Q2 25 | $-0.17 | $0.25 | ||
| Q1 25 | $-0.14 | $0.21 | ||
| Q4 24 | $-3.28 | $-0.24 | ||
| Q3 24 | $-0.03 | $-0.75 | ||
| Q2 24 | $-0.04 | $0.09 | ||
| Q1 24 | $-0.05 | $0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $136.9M |
| 总资产 | $267.0M | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTRBKB
| Q4 25 | $63.4M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $98.2M | — | ||
| Q1 25 | $87.3M | — | ||
| Q4 24 | $100.1M | — | ||
| Q3 24 | $88.6M | — | ||
| Q2 24 | $88.4M | — | ||
| Q1 24 | $80.7M | — |
总债务ASRTRBKB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTRBKB
| Q4 25 | $94.0M | $136.9M | ||
| Q3 25 | $105.8M | $133.0M | ||
| Q2 25 | $93.3M | $129.0M | ||
| Q1 25 | $108.5M | $126.0M | ||
| Q4 24 | $121.1M | $121.8M | ||
| Q3 24 | $130.5M | $122.7M | ||
| Q2 24 | $132.2M | $116.2M | ||
| Q1 24 | $134.5M | $114.3M |
总资产ASRTRBKB
| Q4 25 | $267.0M | $1.3B | ||
| Q3 25 | $319.8M | $1.3B | ||
| Q2 25 | $273.8M | $1.3B | ||
| Q1 25 | $286.4M | $1.3B | ||
| Q4 24 | $284.7M | $1.3B | ||
| Q3 24 | $276.0M | $1.3B | ||
| Q2 24 | $279.4M | $1.3B | ||
| Q1 24 | $282.0M | $1.3B |
负债/权益比ASRTRBKB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $11.7M |
| 自由现金流经营现金流 - 资本支出 | — | $10.9M |
| 自由现金流率自由现金流/营收 | — | 80.6% |
| 资本支出强度资本支出/营收 | — | 6.3% |
| 现金转化率经营现金流/净利润 | — | 5.03× |
| 过去12个月自由现金流最近4个季度 | — | $19.4M |
8季度趋势，按日历期对齐
经营现金流ASRTRBKB
| Q4 25 | $-30.0M | $11.7M | ||
| Q3 25 | $-4.8M | $2.2M | ||
| Q2 25 | $19.1M | $2.4M | ||
| Q1 25 | $-12.5M | $4.3M | ||
| Q4 24 | $11.5M | $8.5M | ||
| Q3 24 | $-35.0K | $-3.6M | ||
| Q2 24 | $7.4M | $12.0M | ||
| Q1 24 | $7.5M | $-3.5M |
自由现金流ASRTRBKB
| Q4 25 | — | $10.9M | ||
| Q3 25 | — | $2.0M | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | — | $4.2M | ||
| Q4 24 | — | $7.7M | ||
| Q3 24 | — | $-3.6M | ||
| Q2 24 | — | $11.8M | ||
| Q1 24 | — | $-3.7M |
自由现金流率ASRTRBKB
| Q4 25 | — | 80.6% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | — | 17.2% | ||
| Q1 25 | — | 32.8% | ||
| Q4 24 | — | 1023.9% | ||
| Q3 24 | — | -469.0% | ||
| Q2 24 | — | 111.1% | ||
| Q1 24 | — | -36.0% |
资本支出强度ASRTRBKB
| Q4 25 | — | 6.3% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 105.5% | ||
| Q3 24 | 0.0% | 6.3% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | 2.3% |
现金转化率ASRTRBKB
| Q4 25 | — | 5.03× | ||
| Q3 25 | -0.42× | 0.83× | ||
| Q2 25 | — | 0.89× | ||
| Q1 25 | — | 1.89× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.27× | ||
| Q1 24 | — | -3.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
RBKB
暂无分部数据
